Clinical trial
The Effect of DLBS1033 in Patients With ST Elevation Acute Coronary Syndrome (STE-ACS) After Primary Percutaneous Coronary Intervention
NCT02976701 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of DLBS1033 in Patients With ST Elevation Acute Coronary Syndrome (STE-ACS) After Primary Percutaneous Coronary Intervention
- Lead sponsor
- Dexa Medica Group
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- November 30, 2016
- Completion date
- March 31, 2023
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.